Prot #ARD-3150-1201: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Pulmaquin® in the Management of Chronic Lung Infections with Pseudomonas aeruginosa in Subjects with Non-Cystic Fibrosis Bronchie

Project: Research project

StatusFinished
Effective start/end date4/7/154/7/18

Funding

  • SynteractHCR, Inc. (Prot #ARD-3150-1201)
  • Aradigm Corporation (Prot #ARD-3150-1201)